Answers are grounded in this paper and cite their sources.
Impaired insulin secretion represents a key feature of type 2 diabetes (T2D), a major global health burden. Insulin release from pancreatic β cells is regulated by G protein–coupled receptors linked to different functional classes of G proteins. The potential metabolic role of β cell G 12/13 (G 12 hereafter) signaling remains unexplored. Thus, we studied the potential metabolic outcomes of β cell G 12 activation by using a combination of mouse gene knockout technology and β cell–specific chemogenetic approaches. We found that selective activation of β cell G 12 signaling strongly promoted insulin secretion, thus protecting mice against obesity-associated metabolic deficits and improving glycemic control in a mouse model of T2D. Mechanistic studies with perifused pancreatic mouse islets identified ROCK as a key downstream effector of G 12 signaling and potent trigger of insulin secretion. Collectively, these findings suggest that G protein–coupled receptors linked to G 12 in β cells represent potential targets for antidiabetic drugs.
No takes yet. Share an insight, caveat, or question.
Pittala et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: